|

Randomized Assessment of TcMS for VT Storm

RECRUITINGN/ASponsored by University of Pennsylvania
Actively Recruiting
PhaseN/A
SponsorUniversity of Pennsylvania
Started2023-05-22
Est. completion2028-07
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05599022

Summary

Three-arm randomized clinical trial comparing two strategies of TcMS to sham stimulation in patients with VT storm. The hypothesis of the study is that TcMS will reduce the burden of VT in the 24 hours after randomization compared to sham stimulation and that TcMS with theta burst stimulation (TBS) will be more effective at reducing VT burden than low frequency TcMS.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* ≥3 episodes of sustained VT or appropriate ICD therapies within 24 hours despite the use of at least one antiarrhythmic drug

Exclusion Criteria:

* Plan for catheter ablation of VT in the next 24 hours
* Pregnancy
* Contraindication to TcMS (i.e. implantable ventricular assist device, metal implanted in the head or neck \[except the mouth\], implanted medication pumps, cochlear implant, implanted brain stimulator, ocular implant, history of malignancy in the neck)

Conditions2

Heart DiseaseVentricular Tachycardia

Locations1 site

Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104
Timothy Markman, MD

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.